Dr Lindsay Rosenwald, Biography.
Wall Street Transcript Interview (2018)
IDB Bank Profile
Biography (2011) LR Facts*, below.
For...
Dyadic (DYAI) Highlights.
"In just over a year and a half we have entered into over 15 proof of concept collaborations for both human and...
Healthcare and Technology Incubator Dalrada (DFCO) Bolsters LikidoONE’s® Clean Technology.
LikidoONE® 'HFC Free' Heat and Refrigeration pump, already a model marvel of engineering technology, anticipates an additional 12% boost in energy cost-cost...
Are Psychedelics the New Prozac?
Amidst a national epidemic of opioid abuse, and suicides the need for new therapeutics has gained greater urgency. In it's first step to...
Immunomedics Chairman Buys $19 Million More in Stock.
(Barrons) Two weeks ago, B. Riley analyst Madhu Kumar gushed about Immunomedics, writing in a report that the biotech could have a “blockbuster cancer drug” in IMMU-132,...
Adding Draganfly (DFLYF) $1.40 to Watch List.
Amnnounces Deal to Supply 3,000 Drones to Steve Wozniak via 'Woz EDU" Partnership.
Doubling Down After ATAI’s (ATAI) Anti Depression Treatment Bombs in Front of FDA.
Both a bad day and a Good day for Psychedelics. The Psychedelic Sector Holds Firm.
Atai was founded in...
OMNIQ (OMQS) $5.00 Reports $15.8 Million 3Q, up 21%.
OMNIQ Corp. Reports Strong Sales of $15.8 Million for Third Quarter of 2020, up 21% Year over Year
GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial!
Results Demonstrate Potential Protective Immunity Against Multiple SARS-CoV-2 Variants
We were having cocktails at...
Silo Pharma (SILO) $2.25, Now Our Favorite Psychedelic.
We Liked it at $3.50, we Love it at $2.25.
Down but not out. Now trading below the...
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
